(Q28217782)

English

CD44 in cancer

scientific article (publication date: November 2002)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

CD44 in cancer (English)

0 references

author name string

David Naor

1

0 references

Shlomo Nedvetzki

2

0 references

Itshak Golan

3

0 references

Lora Melnik

4

0 references

Yoram Faitelson

5

0 references

language of work or name

0 references

publication date

November 2002

0 references

Critical Reviews in Clinical Laboratory Sciences

0 references

39

0 references

527-79

0 references

6

0 references

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795574

25 April 2017

Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795574

25 April 2017

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795574

25 April 2017

Identifiers

10.1080/10408360290795574

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217782&oldid=1217692323"